ILD Clinical Trials in São Paulo, São Paulo
6 recruitingSão Paulo, São Paulo, Brazil
Showing 1–6 of 6 trials
Recruiting
Phase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
ObesityHeart Failure With Preserved Ejection FractionHeart Failure With Mildly Reduced Ejection Fraction
Amgen5,056 enrolled596 locationsNCT07037459
Recruiting
Phase 3
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Chronic Kidney DiseaseProteinuriaChildren
Bayer100 enrolled178 locationsNCT05457283
Recruiting
ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic Biomarkers
Amyloidosis CardiacAmyloidosis, HereditaryWild-type ATTR Amyloidosis+1 more
University of Sao Paulo General Hospital70 enrolled1 locationNCT07314268
Recruiting
Not Applicable
Impact of Remote Vital Signs Monitoring in People Using Long-term Oxygen Therapy
COPDILD
University of Sao Paulo General Hospital60 enrolled1 locationNCT06882265
Recruiting
Phase 4
Sedation Versus Protective Stabilization for Pediatric Dental Treatment
Child BehaviorDental Caries in Children
Universidade Federal de Goias152 enrolled2 locationsNCT04119180
Recruiting
Latin American Surgical Outcomes Study in Pediatric Patients
Postoperative ComplicationsChildren
University of Sao Paulo10,000 enrolled1 locationNCT05934682